Phase I Study of Topical Romidepsin (Depsipeptide) in Early Stage Cutaneous T-Cell Lymphoma.
Latest Information Update: 03 Oct 2021
At a glance
- Drugs Romidepsin (Primary)
- Indications Cutaneous T-cell lymphoma
- Focus Adverse reactions
- 05 Jul 2012 Actual patient number (6) added as reported by ClinicalTrials.gov.
- 05 Jul 2012 Actual patient number (6) added as reported by ClinicalTrials.gov.
- 05 Jul 2012 Actual end date (June 2012) added as reported by ClinicalTrials.gov.